Funding of human stem cell research by the United States

dc.creator	Jones,Phillip B.C.
dc.date	2000-04-01
dc.date.accessioned	2019-11-14T12:55:57Z
dc.date.available	2019-11-14T12:55:57Z
dc.identifier	https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-34582000000100003
dc.identifier.uri	https://revistaschilenas.uchile.cl/handle/2250/117437
dc.description	During the fall of 1998, three research groups announced that they had devised methods for obtaining human embryonic stem cells. Human stem cells are characterized by the ability to form many cell types, and the scientific community anticipates that the cells should be useful for the treatment of a wide variety of diseases. The dilemma is that human stem cell methodology can require, at least to some extent, research with human fetal tissue or research involving human embryos. Those opposed to federal funding of the former are concerned that the studies would support the "legitimacy" of abortion, while the latter is seen as prohibited under current law. The National Bioethics Advisory Committee has suggested that the federal government should fund both activities.
dc.format	text/html
dc.language	en
dc.publisher	Pontificia Universidad Católica de Valparaíso
dc.relation	10.4067/S0717-34582000000100003
dc.rights	info:eu-repo/semantics/openAccess
dc.source	Electronic Journal of Biotechnology v.3 n.1 2000
dc.title	Funding of human stem cell research by the United States